Published in Oral Oncol on December 01, 2002
The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol (2008) 2.58
The association of lymph node volume with cervical metastatic lesions in head and neck cancer patients. Eur Arch Otorhinolaryngol (2008) 1.42
Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer (2010) 1.37
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer (2010) 1.33
Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol Ital (2007) 1.20
Significance of level v lymph node dissection in clinically node positive oral cavity squamous cell carcinoma and evaluation of potential risk factors for level v lymph node metastasis. Indian J Surg Oncol (2013) 1.07
Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol (2011) 0.98
Vision 20/20: perspectives on automated image segmentation for radiotherapy. Med Phys (2014) 0.97
Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol (2008) 0.94
Long non-coding RNA deregulation in tongue squamous cell carcinoma. Biomed Res Int (2014) 0.91
Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol (2010) 0.89
Molecular signatures of metastasis in head and neck cancer. Head Neck (2008) 0.89
Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer (2014) 0.87
Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head Neck (2015) 0.86
Significance of the Extracapsular Spread of Metastatic Lymph Nodes in Papillary Thyroid Carcinoma. Clin Exp Otorhinolaryngol (2015) 0.85
Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis. BMC Cancer (2014) 0.84
Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature. Acta Otorhinolaryngol Ital (2006) 0.81
What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck. Cancer Imaging (2005) 0.81
Impact of difference in the definition of extranodal spread on the outcome of node-positive patients with gastric cancer. Langenbecks Arch Surg (2009) 0.80
Radial displacement of clinical target volume in node negative head and neck cancer. Radiat Oncol J (2012) 0.80
Loss of the α2β1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro. PLoS One (2011) 0.80
Prognostic significance of the degree of extranodal extension in patients with penile carcinoma. Asian J Androl (2014) 0.80
Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastases. Oral Oncol (2015) 0.79
Prognostic biological features in neck dissection specimens. Eur Arch Otorhinolaryngol (2012) 0.79
Lymph node ratio is of limited value for the decision-making process in the treatment of patients with laryngeal cancer. Eur Arch Otorhinolaryngol (2014) 0.79
Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2012) 0.78
Immunohistochemistry, a valuable tool in detection of cervical lymph node micrometastases in head and neck squamous cell carcinoma: a prospective study. Indian J Otolaryngol Head Neck Surg (2012) 0.77
TGFβ3-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis. Sci Rep (2016) 0.77
Sentinel lymph node biopsy versus selective neck dissection for detection of metastatic oral squamous cell carcinoma. Clin Exp Metastasis (2012) 0.76
Level IIb Neck Dissection in Oral Cavity Cancers- When Should One Address it..? Indian J Surg Oncol (2015) 0.75
Dysregulated miR-645 affects the proliferation and invasion of head and neck cancer cell. Cancer Cell Int (2015) 0.75
Cervical node metastasis in T1 squamous cell carcinoma of oral tongue- pattern and the predictive factors. Indian J Surg Oncol (2014) 0.75
Authors' response to the comments by Eckel on the editorial "The future of the TNM staging system in laryngeal cancer: time for a debate?". Eur Arch Otorhinolaryngol (2008) 0.75
Relationship of Tumor Thickness with Neck Node Metastasis in Buccal Squamous Cell Carcinoma: An Experience at a Tertiary Care Hospital. Int Arch Otorhinolaryngol (2017) 0.75
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol (2012) 3.08
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab (2011) 2.93
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
The future of the TNM staging system in laryngeal cancer: time for a debate? Eur Arch Otorhinolaryngol (2008) 2.58
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res (2007) 2.57
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov (2013) 2.49
Paragangliomas of the head and neck. Oral Oncol (2004) 2.47
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol (2006) 2.40
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res (2011) 2.31
Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev (2007) 2.31
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov (2012) 2.31
The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res (2007) 2.30
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov (2013) 2.29
Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21
Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2012) 2.14
Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08
Primary mucosal malignant melanoma of the head and neck. Head Neck (2002) 2.07
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res (2002) 2.05
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid (2014) 2.04
Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg (2004) 2.03
Micromedullary thyroid cancer: how micro is truly micro? Ann Surg Oncol (2009) 1.99
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol (2006) 1.97
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Neuroendocrine neoplasms of the larynx: an overview. Head Neck (2009) 1.92
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 1.80
Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg (2003) 1.74
Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cyst. J Surg Oncol (2002) 1.73
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer (2011) 1.71
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res (2011) 1.71
Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol (2006) 1.70
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med (2007) 1.69
Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg (2008) 1.68
Cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate. Laryngoscope (2006) 1.68
Poorly differentiated and anaplastic thyroid cancer. Cancer Control (2006) 1.66
Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin Cancer Res (2009) 1.66
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease. Clin Cancer Res (2008) 1.63
Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology (2005) 1.59
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2009) 1.58
Thyroglossal duct cyst: personal experience and literature review. Auris Nasus Larynx (2007) 1.57
Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys (2007) 1.57
Mandible fracture patterns: a suburban trauma center experience. Am J Otolaryngol (2004) 1.56
Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol (2012) 1.55
Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab (2007) 1.53
Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg (2004) 1.53
Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res (2010) 1.51
Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo. ACS Nano (2012) 1.49
Transoral resection of short segment Zenker's diverticulum and cricopharyngeal myotomy: an alternative minimally invasive approach. Laryngoscope (2010) 1.49
Parapharyngeal lymph node metastasis: an unusual presentation of papillary thyroid carcinoma. Head Neck (2004) 1.48
Current treatment options for recurrent nasopharyngeal cancer. Eur Arch Otorhinolaryngol (2010) 1.48
LANTCET: elimination of solid tumor cells with photothermal bubbles generated around clusters of gold nanoparticles. Nanomedicine (Lond) (2008) 1.45
Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer (2004) 1.44
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer (2004) 1.43
Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol (2012) 1.43
High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer (2013) 1.43
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer J (2006) 1.42
An outline of the history of head and neck oncology. Oral Oncol (2007) 1.42
Publication misrepresentation among otolaryngology residency applicants. Otolaryngol Head Neck Surg (2010) 1.41
Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer (2003) 1.41
Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol (2010) 1.40
Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck? J Am Coll Surg (2005) 1.39
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol (2010) 1.37
Xenograft models of head and neck cancers. Head Neck Oncol (2009) 1.37
Letter to the editor: impact of prophylactice percutaneous endoscopic gasatrostomy on malnutrition and QOL in patients with head and neck cancer: a randomized study. Head Neck (2012) 1.37
FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol (2006) 1.37
Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer (2005) 1.36
Planned neck dissection for patients with complete response to chemoradiotherapy: a concept approaching obsolescence. Head Neck (2010) 1.34
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck (2010) 1.34
Advances and applications of oral cancer basic research. Oral Oncol (2011) 1.33
Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer (2003) 1.33
Management of sarcomas of the head and neck in adults. Oral Oncol (2003) 1.31
Evidence-based review of treatment options for patients with glottic cancer. Head Neck (2011) 1.30
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer (2009) 1.30
Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol (2009) 1.29
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res (2010) 1.29
Salivary duct carcinoma. Otolaryngol Head Neck Surg (2003) 1.28
Genome-wide appraisal of thyroid cancer progression. Am J Pathol (2002) 1.28
The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg (2003) 1.28
Structural basis for depletion of heat shock protein 90 client proteins by deguelin. J Natl Cancer Inst (2007) 1.27
Neck disease and distant metastases. Oral Oncol (2003) 1.27
Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol (2003) 1.27
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol (2010) 1.27
A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope (2012) 1.26